Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Gilbert

Showing results (51-60 of 173) with videos related to

Pageof 18
Sort By:
Circulation|December 28, 2017
Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)Hertzel C Gerstein, Hyejung Jung, Lars Rydén, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2003
Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney modelDarren J Kelly, Claire Hepper, Leonard L Wu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 16, 2010
Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarctionSih Min Tan, Yuan Zhang, Kim A Connelly, et al.
The Medical Journal of Australia|September 21, 2004
Prevention of cardiovascular disease: an evidence-based clinical aid 2004Greg R Fulcher, John V Amarena, Greg W Conner, et al.
Diabetes Care|May 29, 2002
Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restrictionChristine A Houlihan, Aysel Akdeniz, Con Tsalamandris, et al.
Diabetes Research and Clinical Practice|October 9, 2023
Preconception SGLT2 or DPP4 inhibitor use and adverse pregnancy outcomesJoel G Ray, Ziv Harel, Richard E Gilbert, et al.
Biochemical and Biophysical Research Communications|September 27, 2003
STI-571 inhibits in vitro angiogenesisAndrew Dudley, Richard E Gilbert, David Thomas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 21, 2014
Effect of canagliflozin on blood pressure and adverse events related to osmotic diuresis and reduced intravascular volume in patients with type 2 diabetes mellitusMatthew R Weir, Andrzej Januszewicz, Richard E Gilbert, et al.
Nephrology (Carlton, Vic.)|February 24, 2011
Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathyAndrew Advani, Kathryn J Wiggins, Alison J Cox, et al.
American Journal of Physiology. Renal Physiology|May 25, 2006
Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cellsWeier Qi, Xinming Chen, John Holian, et al.
Pageof 18

Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
Circulation|December 28, 2017
Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)Hertzel C Gerstein, Hyejung Jung, Lars Rydén, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2003
Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney modelDarren J Kelly, Claire Hepper, Leonard L Wu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 16, 2010
Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarctionSih Min Tan, Yuan Zhang, Kim A Connelly, et al.
The Medical Journal of Australia|September 21, 2004
Prevention of cardiovascular disease: an evidence-based clinical aid 2004Greg R Fulcher, John V Amarena, Greg W Conner, et al.
Diabetes Care|May 29, 2002
Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restrictionChristine A Houlihan, Aysel Akdeniz, Con Tsalamandris, et al.
Diabetes Research and Clinical Practice|October 9, 2023
Preconception SGLT2 or DPP4 inhibitor use and adverse pregnancy outcomesJoel G Ray, Ziv Harel, Richard E Gilbert, et al.
Biochemical and Biophysical Research Communications|September 27, 2003
STI-571 inhibits in vitro angiogenesisAndrew Dudley, Richard E Gilbert, David Thomas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 21, 2014
Effect of canagliflozin on blood pressure and adverse events related to osmotic diuresis and reduced intravascular volume in patients with type 2 diabetes mellitusMatthew R Weir, Andrzej Januszewicz, Richard E Gilbert, et al.
Nephrology (Carlton, Vic.)|February 24, 2011
Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathyAndrew Advani, Kathryn J Wiggins, Alison J Cox, et al.
American Journal of Physiology. Renal Physiology|May 25, 2006
Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cellsWeier Qi, Xinming Chen, John Holian, et al.
Pageof 18